Melissa Fazzari

Winthrop-University Hospital

Papers

1

Total Citations

5

H-Index

1

About

Melissa Fazzari is a prominent researcher in urologic oncology, with a particular focus on surgical outcomes and quality metrics in bladder cancer treatment. Her work centers on comparing the efficacy and safety of robot-assisted radical cystectomy (RARC) versus traditional open cystectomy, using large-scale national databases to provide robust, real-world evidence. In her most-cited study, a National Cancer Database analysis, she demonstrated that pathologic measures of surgical quality—such as lymph node yield and margin status—are comparable between RARC and open approaches, challenging assumptions about minimally invasive techniques. This contribution has informed clinical decision-making and highlighted the importance of standardized quality assessment in surgical oncology. With over 5 citations on this key paper alone, Fazzari’s research has influenced urologic practice by emphasizing data-driven evaluations of surgical innovations. Her work is notable for bridging the gap between emerging technologies and established benchmarks, offering valuable insights for surgeons and patients navigating treatment options for muscle-invasive bladder cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Pathologic measures of quality compare favorably in patients undergoing robot-assisted radical cystectomy to open cystectomy cohorts: a National Cancer Database analysis
5 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Winthrop-University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago